(S)-(+)-Glycidyl Phthalimide CAS 161596-47-0 Tsarkakewa

(S)-(+)-Glycidyl Phthalimide CAS 161596-47-0 Tsafta ≥98.0% (HPLC) Rivaroxaban Tsakanin Factory

Takaitaccen Bayani:

Sunan Sinadari: (S)-(+)-Glycidyl Phthalimide

Saukewa: 161596-47-0

Bayyanar: Fari zuwa Kashe-fari foda

Tsafta: ≥98.0% (HPLC)

Matsakaicin Rivaroxaban (CAS: 366789-02-8) a cikin jiyya na Thromboembolism Venous (VTE)

Inquiry: alvin@ruifuchem.com

Aika mana imel

Cikakken Bayani

Samfura masu dangantaka

Tags samfurin

Bayani:

Matsakaicin Matsakaici mai alaƙa da Rivaroxaban Samar da Mai ƙira:
(S)-(+)-Glycidyl Phthalimide CAS 161596-47-0
4- (4-Aminophenyl) morpholin-3-daya CAS 438056-69-0
Rivaroxaban Matsakaici CAS 446292-07-5
5-Chlorothiophene-2-Carboxylic Acid CAS 24065-33-6
5-Chlorothiophene-2-Carbonyl Chloride CAS 42518-98-9
Rivaroxaban API CAS 366789-02-8

Abubuwan Sinadarai:

Sunan Sinadari	(S)-(+)-Glycidyl Phthalimide
Makamantu	(S)-Glycidyl Phthalimide;(S)-N-Glycidylphthalimide;Rivaroxaban Intermediate
Lambar CAS	161596-47-0
Lambar CAT	Saukewa: RF-PI128
Matsayin Hannun jari	A cikin Hannun jari, Ma'aunin samarwa Har zuwa Ton
Tsarin kwayoyin halitta	Saukewa: C11H9NO3
Nauyin Kwayoyin Halitta	203.19
Matsayin narkewa	102 ℃
Alamar	Ruifu Chemical

Ƙayyadaddun bayanai:

Abu	Ƙayyadaddun bayanai
Bayyanar	Fari zuwa Kashe-Farin Foda
Ganewa	HPLC
Asara akan bushewa	≤0.50%
Sulfate ash	≤0.50%
Tsarkake / Hanyar Bincike	≥98.0% (HPLC)
Phthalimide	≤0.10%
Single Max najasa	≤0.50%
Jimlar ƙazanta	≤2.0%
Epichlorohydrin	≤0.10%
Glycidol	≤0.10%
Chiral Tsafta	R-isomer ≤2.0% (HPLC)
Matsayin Gwaji	Matsayin Kasuwanci
Amfani	Rivaroxaban (CAS: 366789-02-8) Matsakaici

(S)-(+)-Glycidyl Phthalimide CAS: 161596-47-0 Hanyar Haɗawa

Kunshin & Ajiya:

Amfani:

FAQ:

Aikace-aikace:

Shanghai Ruifu Chemical Co., Ltd. shine babban masana'anta kuma mai ba da kaya na (S)-(+) - Glycidyl Phthalimide (CAS: 161596-47-0) tare da babban inganci.Matsakaici ne yawanci a cikin kirar Rivaroxaban (CAS: 366789-02-8), a cikin jiyya na Thromboembolism Venous (VTE).

Rivaroxaban (Xarelto; CAS: 366789-02-8) maganin rigakafin thrombotic ne kuma an ƙirƙira shi ta hanyar haɗin gwiwar Jamus Bayer Pharmaceuticals da kamfanin American Johnson.Ana nuna Rivaroxaban don maganin thrombosis mai zurfi da huhu na huhu, da kuma rigakafin ciwon daji mai zurfi mai maimaitawa da ciwon huhu a cikin manya.